BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29233468)

  • 1. Butyrate suppresses motility of colorectal cancer cells via deactivating Akt/ERK signaling in histone deacetylase dependent manner.
    Li Q; Ding C; Meng T; Lu W; Liu W; Hao H; Cao L
    J Pharmacol Sci; 2017 Dec; 135(4):148-155. PubMed ID: 29233468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of butyrate analogues on apoptosis, proliferation and histone deacetylase activity in HCT-116 human colorectal cancer cells.
    Ooi CC; Good NM; Williams DB; Lewanowitsch T; Cosgrove LJ; Lockett TJ; Head RJ
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):905-11. PubMed ID: 20497425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrate inhibits the proliferation and induces the apoptosis of colorectal cancer HCT116 cells via the deactivation of mTOR/S6K1 signaling mediated partly by SIRT1 downregulation.
    Cao M; Zhang Z; Han S; Lu X
    Mol Med Rep; 2019 May; 19(5):3941-3947. PubMed ID: 30864709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential pathways involved in induction of apoptosis by butyrate and 4-benzoylbutyrate in HT29 colorectal cancer cells.
    Fung KY; Ooi CC; Lewanowitsch T; Tan S; Tan HT; Lim TK; Lin Q; Williams DB; Lockett TJ; Cosgrove LJ; Chung MC; Head RJ
    J Proteome Res; 2012 Dec; 11(12):6019-29. PubMed ID: 23057685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
    Trtková K; Pašková L; Matiješčuková N; Kolář Z
    Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells.
    Yang L; Liang Q; Shen K; Ma L; An N; Deng W; Fei Z; Liu J
    Biomed Pharmacother; 2015 Apr; 71():70-8. PubMed ID: 25960218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.
    Hu S; Liu L; Chang EB; Wang JY; Raufman JP
    Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SCFA butyrate stimulates the epithelial production of retinoic acid via inhibition of epithelial HDAC.
    Schilderink R; Verseijden C; Seppen J; Muncan V; van den Brink GR; Lambers TT; van Tol EA; de Jonge WJ
    Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1138-46. PubMed ID: 27151945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling.
    Kibbie JJ; Dillon SM; Thompson TA; Purba CM; McCarter MD; Wilson CC
    Immunobiology; 2021 Sep; 226(5):152126. PubMed ID: 34365090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer.
    Li Y; Liu Y; Zhao N; Yang X; Li Y; Zhai F; Zang X; Cui W
    Cell Death Dis; 2020 Sep; 11(9):753. PubMed ID: 32934224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex.
    Walker GE; Wilson EM; Powell D; Oh Y
    Endocrinology; 2001 Sep; 142(9):3817-27. PubMed ID: 11517158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrate inhibits seeding and growth of colorectal metastases to the liver in mice.
    Velázquez OC; Jabbar A; DeMatteo RP; Rombeau JL
    Surgery; 1996 Aug; 120(2):440-7; discussion 447-8. PubMed ID: 8751616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
    Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
    Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species.
    Rahmani M; Reese E; Dai Y; Bauer C; Payne SG; Dent P; Spiegel S; Grant S
    Cancer Res; 2005 Mar; 65(6):2422-32. PubMed ID: 15781658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of Spleen Tyrosine Kinase (Syk) by Histone Deacetylation Promotes, Whereas BAY61-3606, a Synthetic Syk Inhibitor Abrogates Colonocyte Apoptosis by ERK Activation.
    Dasgupta N; Thakur BK; Ta A; Dutta P; Das S
    J Cell Biochem; 2017 Jan; 118(1):191-203. PubMed ID: 27293079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway.
    Wei J; Zheng Z; Hou X; Jia F; Yuan Y; Yuan F; He F; Hu L; Zhao L
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116866. PubMed ID: 37429503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC3 overexpression and colon cancer cell proliferation and differentiation.
    Spurling CC; Godman CA; Noonan EJ; Rasmussen TP; Rosenberg DW; Giardina C
    Mol Carcinog; 2008 Feb; 47(2):137-47. PubMed ID: 17849419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
    Sekhavat A; Sun JM; Davie JR
    Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.
    Strobl JS; Cassell M; Mitchell SM; Reilly CM; Lindsay DS
    J Parasitol; 2007 Jun; 93(3):694-700. PubMed ID: 17626366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoblastoma protein is required for efficient colorectal carcinoma cell apoptosis by histone deacetylase inhibitors in the absence of p21Waf.
    Wagner S; Roemer K
    Biochem Pharmacol; 2005 Apr; 69(7):1059-67. PubMed ID: 15763542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.